Cite
HARVARD Citation
Kumar, S. et al. (2017). Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma. British journal of haematology. pp. 571-582. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kumar, S. et al. (2017). Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma. British journal of haematology. pp. 571-582. [Online].